Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Crisis Prevention in Pharmacovigilance

Posted on October 12th, 2016 by in Pharmacovigilance

One of the challenging situations that Pharmacovigilance functions will have to manage one day or another is a pharmacovigilance crisis. (more…)

R&D Innovation & Pharma Drug-Device Pricing

Posted on September 26th, 2016 by in Pharma R&D

The media as of late has given a lot of coverage to the “price gouging” that pharmaceutical company Mylan engaged in with its injection device EpiPen. (more…)

Women and minorities in clinical trials

Posted on September 16th, 2016 by in Pharma R&D

You are a female and/or a minority and concerned if you will respond to your medication. So you read the product label, asking yourself, “Do I see myself described as a patient in the drug testing trials?” (more…)

DEA Says No to Schedule II for Marijuana

Posted on September 5th, 2016 by in Pharma R&D

This month, in response to petitions from the former governors of Rhode Island and Washington and from a psychiatric nurse in New Mexico, the U.S. Drug Enforcement Agency (DEA) announced its decision to keep marijuana classified as a Schedule I controlled substance. (more…)

  1. 1
  2. 5
  3. 6
  4. 7
  5. 8
  6. 9